difference in glp 1 and semaglutide vs. Tirzepatide: Which GLP-1 Wins? GLP-1 Medications Explained: Dosage Chart,

Journal of molecular endocrinology

A recent retrospective cohort study looked at GLP-1 adherence in patients with obesity and with/without diabetes: Those with T2DM: 46.5% discontinued by year one 64.1% discontinued by year two Those without T2DM: 64.8% discontinued by year one 84.4% discontinued by year two So yes access is a problem

The first patients DBS treatment was interrupted due to lead wire breakage, and the second patient developed an infection that led to the removal of their DBS system

Some over-the-counter medications may interact with Retatrutide

Depression was the most commonly reported adverse event of the total reports (n = 187

Outpatient management of hyperkalemia involves assessing the patients intercurrent health, reviewing their medications to identify potential culprits, addressing comorbidities, and, if necessary, initiating the use of additional medications (e.g., diuretics, sodium-glucose cotransporter-2 inhibitors) to manage underlying conditions